Clinical Trials Browser

Phase 1/2 × NIH × pomalidomide × Clear all

NCT07463807 2026-03-19

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

Phase 1/2 Not yet recruiting

Multiple Myeloma

NCT01495598 2022-11-01

Pomalidomide for Kaposi Sarcoma in People With or Without HIV

Phase 1/2 Completed

28 enrolled 23 charts

Sarcoma, Kaposi

NCT02228512 2018-08-31

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Phase 1/2 Withdrawn

Lymphoma, Primary Effusion